PGLYRP2 as a novel biomarker for the activity and lipid metabolism of systemic lupus erythematosus

BACKGROUND: To assess the value of peptidoglycan recognition protein 2 (PGLYRP2) in assessing the disease activity and lipid metabolism in patients with systemic lupus erythematosus (SLE). METHODS: SLE patients with stable disease (n = 15), active lupus nephritis (LN) (n = 15) and neuropsychiatric s...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hui, Meng, Defang, Jia, Jieting, Wei, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404349/
https://www.ncbi.nlm.nih.gov/pubmed/34461924
http://dx.doi.org/10.1186/s12944-021-01515-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404349/
https://www.ncbi.nlm.nih.gov/pubmed/34461924
http://dx.doi.org/10.1186/s12944-021-01515-8

Ejemplares similares